NBT Bank’s Quest Diagnostics DGX Stock Holding History

NBT Bank’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27K	Hold	6	–	–	﹤0.01%	944
2026 Q1	$1.18K	Buy	+6	New	+$1.17K	﹤0.01%	916

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

NBT Bank's DGX Position: Q2 2026 in Review

NBT Bank held its Quest Diagnostics (DGX) position steady in Q2 2026 at 6 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #944.

NBT Bank first reported a position in DGX in Q1 2026 and has held it in 2 quarters since. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

NBT Bank held 6 shares of Quest Diagnostics worth $1.27K as of Q2 2026.
NBT Bank left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of NBT Bank's portfolio in Q2 2026, its #944 holding.
NBT Bank first reported a position in Quest Diagnostics in Q1 2026 and has held it in 2 quarters since.
1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on NBT Bank's 13F filing for Q2 2026, filed 29 Jul 2026.